AC Immune Announces Appointment of Dr. Marie Kosco-Vilbois as Chief Scientific Officer
AC Immune SA, a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on Neurodegenerative Diseases, today announced that it has appointed Dr. Marie Kosco-Vilbois, as Chief Scientific Officer, effective January 3, 2019.